Innospec expands partnership with IJM to protect palm oil workers

ENGLEWOOD, Colo. - Innospec Inc. (NASDAQ:IOSP), a specialty chemicals company with a market capitalization of $2.1 billion, announced Tuesday it has entered the second year of its partnership with International Justice Mission (IJM) focused on protecting palm oil workers in Indonesia from forced labor and human trafficking. According to InvestingPro data, the company maintains strong financial health with more cash than debt on its balance sheet.

The specialty chemicals company, which has maintained dividend payments for 14 consecutive years and currently offers a dividend yield of 1.94%, reported that during the first year of collaboration, the partnership trained over 50 law enforcement and government officials on human rights, promoted a digital complaint system for workers to report violations, and launched a national awareness campaign on human trafficking.

For 2025, the partnership will expand to additional Indonesian provinces including Sumatra and the Riau Islands, with plans to implement aftercare systems for survivors of forced labor.

"We believe that protecting workers’ rights is not just a moral obligation but also fundamental to building sustainable supply chains," said Bruce McDonald, President of Performance Chemicals at Innospec, in the press release.

Peter Williams, IJM’s Regional President for Asia Pacific, stated the partnership "has been instrumental in advancing IJM’s mission to uphold dignity, fairness and justice in supply chains."

The collaboration, which began in 2024, aims to strengthen protections for vulnerable workers within Indonesia’s palm oil industry. The initiative has also provided advocacy training for labor representatives and expanded trauma-informed care for survivors.

Innospec, which employs approximately 2,450 people across 22 countries, manufactures specialty chemicals for various markets including personal care, home care, fuel additives, and oil and gas exploration. The company generated revenues of $1.79 billion in the last twelve months, with a healthy current ratio of 2.87. InvestingPro analysis reveals 10+ additional key insights about Innospec’s financial performance and market position, available through their comprehensive Pro Research Report.

In other recent news, Innospec Inc. reported its second-quarter 2025 earnings, showing a mixed performance. The company achieved an earnings per share (EPS) of $1.26, which slightly exceeded the forecast of $1.24, resulting in a 1.61% surprise. However, Innospec’s revenue reached $439.7 million, falling short of the anticipated $440.7 million by 0.23%. This revenue shortfall has raised concerns among investors about potential margin pressures. Despite the minor EPS beat, the company’s stock experienced a decline, reflecting these investor concerns. These developments highlight the challenges Innospec faces in balancing earnings growth with revenue expectations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.